| 000 | 00973 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250516231347.0 | ||
| 264 | 0 | _c20170413 | |
| 008 | 201704s 0 0 eng d | ||
| 022 | _a1544-2217 | ||
| 024 | 7 |
_a10.1177/0300985814547282 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRyan, A M | |
| 245 | 0 | 0 |
_aFrontiers in nonclinical drug development: biosimilars. _h[electronic resource] |
| 260 |
_bVeterinary pathology _cMar 2015 |
||
| 300 |
_a419-26 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntibodies, Monoclonal |
| 650 | 0 | 4 | _aBiosimilar Pharmaceuticals |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 | _aDrug Substitution |
| 650 | 0 | 4 | _aLegislation, Drug |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 773 | 0 |
_tVeterinary pathology _gvol. 52 _gno. 2 _gp. 419-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/0300985814547282 _zAvailable from publisher's website |
| 999 |
_c24134047 _d24134047 |
||